What can be a better model than diseased cells…
When that’s what we intend to treat
OncoPrimeTM Platform can help you to
- Screen new chemical or biological entities for optimal efficacy
- Systematically screen cancers prevalent in India against a ‘pill box’
- Repurpose drugs / combinations to derive novel IP and get to market faster
- Investigate unique tumor characteristics of Indian patients by gene profiling
- Generate patient response data by combining in vitro assays with clinical outcomes
OncoPrimeTM can be used in multitude of ways…
- Primary cell phenotypic screening assays for phenotypic drug discovery (PDD)
- Disease modeling & MoA studies using normal and diseased primary cells, CSCs/CTCs, hESCs/iPSCs etc
- Novel disease models engineered from primary cells (EMT/MET – available; others in pipeline)
- Toxicology assessment using hESCs and hiPSCs Fresh tissues available across variety of indications & pathologies; Oncology, CNS, CVS, hematology, immunology, dermatology etc
- FFPE tissue collection for retrospective studies e.g. disease recurrence